Literature DB >> 16508755

Activated protein C: do more survive?

Saxon Ridley.   

Abstract

Mesh:

Substances:

Year:  2006        PMID: 16508755     DOI: 10.1007/s00134-006-0088-7

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  5 in total

1.  Assessing the use of activated protein C in the treatment of severe sepsis.

Authors:  Jay P Siegel
Journal:  N Engl J Med       Date:  2002-09-26       Impact factor: 91.245

2.  Risks and benefits of activated protein C treatment for severe sepsis.

Authors:  H Shaw Warren; Anthony F Suffredini; Peter Q Eichacker; Robert S Munford
Journal:  N Engl J Med       Date:  2002-09-26       Impact factor: 91.245

3.  Activated protein C for severe sepsis.

Authors:  E Wesley Ely; Gordon R Bernard; Jean-Louis Vincent
Journal:  N Engl J Med       Date:  2002-09-26       Impact factor: 91.245

4.  Activated protein C: do more survive?

Authors:  Alasdair F Mackenzie
Journal:  Intensive Care Med       Date:  2005-10-15       Impact factor: 17.440

5.  Drotrecogin alfa (activated) treatment in severe sepsis from the global open-label trial ENHANCE: further evidence for survival and safety and implications for early treatment.

Authors:  Jean-Louis Vincent; Gordon R Bernard; Richard Beale; Christopher Doig; Christian Putensen; Jean-Francois Dhainaut; Antonio Artigas; Roberto Fumagalli; William Macias; Theressa Wright; Kar Wong; David P Sundin; Mary Ann Turlo; Jonathan Janes
Journal:  Crit Care Med       Date:  2005-10       Impact factor: 7.598

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.